WEDNESDAY, Dec. 3, 2025 (HealthDay News) -- The oral small-molecule glucagon-like peptide 1 (GLP-1) receptor agonist orforglipron demonstrates superior weight l
Oral GLP-1 Receptor Agonist Orforglipron Beneficial for Adults With Obesity, T2DM
HealthDayJust now
93


Raw Story
The Conversation
Bozeman Daily Chronicle
The Babylon Bee
Psychology Today
Associated Press US and World News Video
AlterNet